Correction: The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma.

Autor: Feng, Mei, Xu, Hao, Zhou, Wenyuan, Pan, Yisheng
Předmět:
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966); 7/20/2024, Vol. 43 Issue 1, p1-4, 4p
Abstrakt: This document is a correction notice for an article titled "The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma." The authors identified minor errors in the image-typesetting in Figure 3 of the original article. The image for the NCI-N87 cell line in Figure 3C was mistakenly included, and the corresponding statistical analysis for NCI-N87 in Figure 3D needs to be corrected. The corrected figure has been provided, and the correction does not affect the results or conclusions of the paper. The correction notice is authored by Mei Feng, Hao Xu, Wenyuan Zhou, and Yisheng Pan. [Extracted from the article]
Databáze: Complementary Index
Nepřihlášeným uživatelům se plný text nezobrazuje